"The stock remains at a discounted level versus historical ranges," Cherny said. "The peer set may offer growth-adjusted valuation that are also appealing, but for CVS, it is closer to the end of its ...
28m
uk.investing.com on MSNCVS Health reward 'positively skewed'CVS Health is seeing signs of stabilization in key business areas, prompting Leerink Partners to upgrade the stock from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results